Muscle-Specific PPARβ/δ Agonism May Provide Synergistic Benefits with Life Style Modifications
2007
Muscle-Specific PPARβ/δ Agonism and Its Benefits
publication
Evidence: moderate
Author Information
Author(s): Erol Adnan
Primary Institution: Department of Internal Medicine, Faculty of Medicine, Celal Bayar University, Manisa, Turkey
Hypothesis
Muscle-specific PPARβ/δ agonists could be a key strategy to support the poor cardiorespiratory fitness associated with metabolic disorders.
Conclusion
Targeting PPARβ/δ in skeletal muscle may help prevent metabolic disorders like insulin resistance and obesity by enhancing lipid catabolism.
Supporting Evidence
- Activation of PPARβ/δ enhances mitochondrial capacity and fat oxidation in skeletal muscle.
- PPARβ/δ is expressed at higher levels in skeletal muscle compared to other tissues.
- Muscle-specific PPARβ/δ overexpression promotes a shift toward smaller adipocyte size.
Takeaway
This study suggests that a special type of medicine can help muscles use fat better, which might help people who don't exercise much stay healthy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website